Evidence map›Paper›PMID 42418308›Full record

ArticleCurrent protocols2026

High Throughput In vivo Imaging; A Pipeline for Automated Analysis of Longitudinal Preclinical Studies.

Mark Tchinov, Zachary Gurberg, Diana Möckel, Stefanie Rosenhain, Joseph Marsilio, Sarah Schraven, Kendahl Ott, Aaron LeBeau, Randall J Kimple, Felix Gremse

Abstract read
In one paragraph

Article in Current protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mark TchinovGremse-IT GmbH, Research and Development, Aachen, Germany.
Zachary GurbergGremse-IT GmbH, Research and Development, Aachen, Germany.
Diana MöckelGremse-IT GmbH, Research and Development, Aachen, Germany.
Stefanie RosenhainGremse-IT GmbH, Research and Development, Aachen, Germany.
Joseph MarsilioGremse-IT GmbH, Research and Development, Aachen, Germany.ORCID https://orcid.org/0009-0006-6077-6224
Sarah SchravenGremse-IT GmbH, Research and Development, Aachen, Germany.
Kendahl OttUW Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin.ORCID https://orcid.org/0009-0004-1369-6550
Aaron LeBeauUW Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin.ORCID https://orcid.org/0000-0003-3802-7789
Randall J KimpleUW Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin.
Felix GremseGremse-IT GmbH, Research and Development, Aachen, Germany.

Funding

EU IHI Project IMAGIO 101112053
6 · The paper itself

Abstract

Fast acquisition times, multi-animal beds, and improved accessibility of preclinical imaging systems have enabled high-throughput imaging, significantly accelerating in vivo experimentation. However, image analysis remains largely manual, labor-intensive, and inefficient, with significant inter- and intra-user variability, adding to the already lengthy timeline of preclinical validation. This article outlines an end-to-end pipeline for image acquisition and subject preprocessing, followed by deep learning-based segmentation and reporting of metrics relevant for validation. This pipeline is applicable to imaging studies investigating biodistribution, dosimetry, disease progression, and treatment effect over time. A longitudinal positron emission tomography-computed tomography (PET-CT) case study is used to demonstrate the protocol in a practical animal research context. The protocol encompasses image acquisition and reconstruction, fusion, cropping, sorting, metadata addition, deep learning-based and interactive organ and tumor segmentation, 3-dimensional visualization, and extraction of quantitative uptake curves. © 2026 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Image Acquisition and Reconstruction Basic Protocol 2: Multi-Subject Cropping and Sorting Basic Protocol 3: Atlas Alignment and Segmentation Basic Protocol 4: Quantitation and Reporting.

Indexed as

High-Throughput Screening AssaysImage Processing, Computer-AssistedPositron Emission Tomography Computed TomographyAnimalsDeep LearningHumansLongitudinal StudiesMiceAI segmentationautomated biodistributionHigh‐throughputlongitudinal in vivo imagingPET‐CTradiopharmaceuticalsSPECT‐CT

Identifiers

PMID42418308
PMCPMC13344865

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.